Page 7847
Jan 20, 2018
You could soon be manufacturing your own drugs—thanks to 3D printing
Posted by Derick Lee in categories: 3D printing, biotech/medical, chemistry
But it remains to be seen whether drug regulators will go along with a new way of making medicines. To do so, agencies like the U.S. Food and Drug Administration will need to rewrite their rules for validating the safety of medicines. Instead of signing off on the production facility and manufactured drug samples, regulators would have to validate that reactionware produces the desired medication. Cronin agrees it’s a hurdle. But he argues that future printed reactors could simply include a final module containing standard validation tests that produce a visual readout, much like a pregnancy test. “I think it’s manageable.”
Digitized chemistry on demand could also undermine drug counterfeiters.
Jan 20, 2018
Macromolecular Damage Ages Us Prematurely
Posted by Brady Hartman in categories: biotech/medical, life extension
Macromolecular damage contributes to the chronic diseases of aging. Geroscientists hope to repair the damage by inducing autophagy.
Jan 20, 2018
First FDA-Approved Clinical Trial of Rapamycin the Anti-Aging Drug in Healthy Seniors
Posted by Brady Hartman in categories: biotech/medical, life extension
Looking back at best of 2017)
A clinical trial of rapamycin on healthy seniors. The anti-aging drug extends the lifespan of mice and reduces inflammation markers.
Jan 20, 2018
Can We Slow Aging in our Bodies with Intermittent Rapamycin Therapy?
Posted by Brady Hartman in categories: biotech/medical, life extension
Looking back at best of 2017)
The finding was a milestone in the field of anti-aging science. Professor Judith Campisi, Ph.D., a celebrity in the anti-aging field, and lead author of the study remarked
“Imagine the possibility of taking a pill [rapamycin] for a few days or weeks every few years, as opposed to taking something with side effects every day for the rest of your life. It’s a new way of looking at how we could deal with age-related maladies.” – Judith Campisi, PhD
Continue reading “Can We Slow Aging in our Bodies with Intermittent Rapamycin Therapy?” »
Jan 20, 2018
Revolutionary CRISPR Gene Editing with Nanoparticles
Posted by Brady Hartman in categories: bioengineering, biotech/medical, life extension, nanotechnology
Looking back at best of 2017)
Summary: Nanotechnology meets gene editing. MIT researchers use nanoparticles instead of viruses to deliver the CRISPR gene editing system. This article first appeared on LongevityFacts. Author: Brady Hartman]
In a new study, MIT scientists have developed nanoparticles that deliver the CRISPR gene editing system, eliminating the need to use viruses for delivery.
Continue reading “Revolutionary CRISPR Gene Editing with Nanoparticles” »
Jan 20, 2018
Incredibly Rare ‘Super Blue Blood Moon’ Is About to Appear For The First Time in 150 Years
Posted by Shailesh Prasad in categories: biotech/medical, space
If you were awestruck by the New Year’s Day super moon, hold onto your pants.
On January 31, around midnight, the full moon will not only be super, it will be a blue moon and a blood moon.
The blue moon comes as it will be the second full moon in a month. That happens every two and a half years, hence the saying “once in a blue moon”.
Jan 20, 2018
Bitcoin Wallet Maker Ledger Raises $75 Million for Security Push
Posted by Klaus Baldauf in categories: bitcoin, cryptocurrencies, security
Ledger SAS, a startup that makes electronic wallets for Bitcoin and other cryptocurrencies, has raised 61 million euros ($75 million) from investors including Draper Esprit Plc.
Jan 20, 2018
Space mining is going to seriously disrupt Earth’s economy. And we’re nowhere near ready for the shock
Posted by Klaus Baldauf in categories: economics, space
In the coming decades, the mining of precious minerals in space is likely to have a major impact on the global economy. And existing laws are nowhere near ready for the shift.
Jan 20, 2018
Army Grapples With Cyber Age Battles In Megacities
Posted by Klaus Baldauf in categories: 3D printing, biotech/medical, drones, law, military, terrorism
High-tech warfare at knife-fight ranges: that’s the ugly future of urban combat. If you thought Baghdad was bad, with its roughly six million people, imagine a “megacity” of 10 or 20 million, where the slums have more inhabitants than some countries. Imagine a city of the very near future where suspicious locals post every US military movement on Twitter with digital photos and GPS-precise coordinates. Imagine roadside bombs that fly because the bad guys downloaded blueprints for a kamikaze mini-drone and built it with their 3D printer.
As the US pulls out of the mountains and deserts of Afghanistan, the Navy and Air Force may be looking to the wide-open Pacific, but the Army is increasingly concerned about the cramped alleyways of Third World cities. (The Marines, as usual, have a foot in both worlds). Chief of Staff Ray Odierno’s personal Strategic Studies Group — now led by hybrid warfare expert David Johnson — is working on the subject, as is the Army’s think tank and teaching institution, Training and Doctrine Command (TRADOC). This August, after months of seminars, simulations, and study, the Army War College will host a “deep future wargame” set in a megacity, probably a coastal one, circa 2035.
Continue reading “Army Grapples With Cyber Age Battles In Megacities” »